Article | 18 March 2025

Protected: Important decision on the distinction between marketing and non-commercial information in relation to medicinal products

Responsive image

This content is password protected. To view it please enter your password below:

Contact:

Helena Nilsson, Lovisa Dahl Nelson

Practice areas:

Life Sciences

  • This field is for validation purposes and should be left unchanged.

Do you want to get in touch with us?

Please fill out the form and we will contact you as soon as possible.

Related news

Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordination of price levels on generic drugs

Uppdrag | 3 March 2025

Setterwalls advised in connection with the Swedish Competition Authority’s investigation of suspected coordina...

Read more
Setterwalls advised Integrum AB in connection with a private placement of approximately SEK 31 million

Uppdrag | 20 February 2025

Setterwalls advised Integrum AB in connection with a private placement of approximately SEK 31 million

Read more
Part II: The relationship between the GDPR and the AI Act

Article | 28 January 2025

Part II: The relationship between the GDPR and the AI Act

Read more
Load more